Structure

Physi-Chem Properties

Molecular Weight:  292.11
Volume:  308.233
LogP:  5.392
LogD:  4.23
LogS:  -4.046
# Rotatable Bonds:  1
TPSA:  42.6
# H-Bond Aceptor:  3
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.687
Synthetic Accessibility Score:  2.637
Fsp3:  0.158
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.729
MDCK Permeability:  1.2938051440869458e-05
Pgp-inhibitor:  0.992
Pgp-substrate:  0.104
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.013
30% Bioavailability (F30%):  0.599

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.045
Plasma Protein Binding (PPB):  100.21923065185547%
Volume Distribution (VD):  0.823
Pgp-substrate:  1.2312840223312378%

ADMET: Metabolism

CYP1A2-inhibitor:  0.987
CYP1A2-substrate:  0.325
CYP2C19-inhibitor:  0.96
CYP2C19-substrate:  0.071
CYP2C9-inhibitor:  0.781
CYP2C9-substrate:  0.943
CYP2D6-inhibitor:  0.958
CYP2D6-substrate:  0.902
CYP3A4-inhibitor:  0.886
CYP3A4-substrate:  0.303

ADMET: Excretion

Clearance (CL):  6.795
Half-life (T1/2):  0.206

ADMET: Toxicity

hERG Blockers:  0.432
Human Hepatotoxicity (H-HT):  0.732
Drug-inuced Liver Injury (DILI):  0.859
AMES Toxicity:  0.037
Rat Oral Acute Toxicity:  0.147
Maximum Recommended Daily Dose:  0.771
Skin Sensitization:  0.53
Carcinogencity:  0.776
Eye Corrosion:  0.003
Eye Irritation:  0.687
Respiratory Toxicity:  0.812

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC272194

Natural Product ID:  NPC272194
Common Name*:   Gramniphenol F
IUPAC Name:   4-(7,7-dimethylfuro[3,2-g]chromen-2-yl)phenol
Synonyms:   Gramniphenol F
Standard InCHIKey:  GQRJEBZESAXFAK-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C19H16O3/c1-19(2)8-7-13-9-14-10-16(12-3-5-15(20)6-4-12)21-17(14)11-18(13)22-19/h3-11,20H,1-2H3
SMILES:  Oc1ccc(cc1)c1oc2c(c1)cc1c(c2)OC(C=C1)(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2333780
PubChem CID:   71579377
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33109 arundina gramnifolia Species Orchidaceae Eukaryota n.a. n.a. n.a. PMID[23368966]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1452 Cell Line C8166 Homo sapiens CC50 = 102.5 ug.mL-1 PMID[496118]
NPT786 Organism Tobacco mosaic virus Tobacco mosaic virus IC50 = 40800.0 nM PMID[496118]
NPT786 Organism Tobacco mosaic virus Tobacco mosaic virus Inhibition = 35.8 % PMID[496118]
NPT786 Organism Tobacco mosaic virus Tobacco mosaic virus Inhibition = 33.8 % PMID[496118]
NPT27 Others Unspecified Ratio CC50/EC50 = 19.6 n.a. PMID[496118]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 5.22 ug.mL-1 PMID[496118]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC272194 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.993 High Similarity NPC221868
0.993 High Similarity NPC37208
0.9718 High Similarity NPC210826
0.9718 High Similarity NPC300267
0.9718 High Similarity NPC51641
0.9716 High Similarity NPC225884
0.9658 High Similarity NPC472462
0.965 High Similarity NPC130581
0.965 High Similarity NPC12148
0.9583 High Similarity NPC135325
0.9577 High Similarity NPC17262
0.9517 High Similarity NPC296030
0.9517 High Similarity NPC37226
0.9517 High Similarity NPC39929
0.9517 High Similarity NPC226644
0.9504 High Similarity NPC475680
0.9504 High Similarity NPC305355
0.9463 High Similarity NPC268360
0.9463 High Similarity NPC65504
0.9452 High Similarity NPC230713
0.9452 High Similarity NPC78335
0.9441 High Similarity NPC302181
0.9437 High Similarity NPC118840
0.9437 High Similarity NPC156590
0.9437 High Similarity NPC205006
0.9437 High Similarity NPC147688
0.9437 High Similarity NPC64908
0.9392 High Similarity NPC122365
0.9392 High Similarity NPC213608
0.9392 High Similarity NPC72370
0.9392 High Similarity NPC1477
0.9388 High Similarity NPC170169
0.9384 High Similarity NPC178202
0.9375 High Similarity NPC230943
0.9375 High Similarity NPC311741
0.9375 High Similarity NPC234629
0.9371 High Similarity NPC11561
0.9371 High Similarity NPC53192
0.9371 High Similarity NPC144499
0.9371 High Similarity NPC226636
0.9366 High Similarity NPC270883
0.9366 High Similarity NPC172986
0.9366 High Similarity NPC261227
0.9366 High Similarity NPC235239
0.9329 High Similarity NPC99199
0.9324 High Similarity NPC5871
0.9315 High Similarity NPC168085
0.9306 High Similarity NPC38219
0.9306 High Similarity NPC18585
0.9306 High Similarity NPC219915
0.9306 High Similarity NPC106985
0.9306 High Similarity NPC166138
0.9301 High Similarity NPC110969
0.9301 High Similarity NPC103362
0.9296 High Similarity NPC301217
0.9296 High Similarity NPC303633
0.9296 High Similarity NPC96565
0.9296 High Similarity NPC216978
0.9296 High Similarity NPC220062
0.9296 High Similarity NPC55018
0.9291 High Similarity NPC228661
0.9262 High Similarity NPC235333
0.9252 High Similarity NPC317492
0.9247 High Similarity NPC237635
0.9247 High Similarity NPC79469
0.9247 High Similarity NPC24673
0.9247 High Similarity NPC201731
0.9247 High Similarity NPC104406
0.9247 High Similarity NPC97716
0.9241 High Similarity NPC278175
0.9241 High Similarity NPC257236
0.9236 High Similarity NPC299080
0.9236 High Similarity NPC217083
0.9236 High Similarity NPC293852
0.9236 High Similarity NPC78803
0.9236 High Similarity NPC62840
0.9236 High Similarity NPC59739
0.9236 High Similarity NPC214236
0.9231 High Similarity NPC28337
0.9231 High Similarity NPC69769
0.9231 High Similarity NPC150522
0.9231 High Similarity NPC241100
0.9231 High Similarity NPC159275
0.9225 High Similarity NPC201395
0.9216 High Similarity NPC219861
0.9205 High Similarity NPC260902
0.9205 High Similarity NPC296957
0.92 High Similarity NPC198490
0.92 High Similarity NPC148938
0.92 High Similarity NPC297531
0.92 High Similarity NPC213936
0.9195 High Similarity NPC31627
0.9195 High Similarity NPC476238
0.9195 High Similarity NPC327269
0.9195 High Similarity NPC285623
0.9189 High Similarity NPC167576
0.9184 High Similarity NPC266572
0.9184 High Similarity NPC6511
0.9178 High Similarity NPC477955
0.9178 High Similarity NPC124729
0.9172 High Similarity NPC24821
0.9172 High Similarity NPC11700
0.9172 High Similarity NPC9117
0.9172 High Similarity NPC293053
0.9172 High Similarity NPC212932
0.9172 High Similarity NPC190637
0.9167 High Similarity NPC282300
0.9167 High Similarity NPC14871
0.9161 High Similarity NPC53181
0.9161 High Similarity NPC18260
0.9161 High Similarity NPC78913
0.9161 High Similarity NPC217186
0.9155 High Similarity NPC62735
0.9149 High Similarity NPC151113
0.9149 High Similarity NPC163029
0.9145 High Similarity NPC40583
0.9145 High Similarity NPC244750
0.9139 High Similarity NPC160015
0.9139 High Similarity NPC247677
0.9133 High Similarity NPC183874
0.9128 High Similarity NPC193976
0.9128 High Similarity NPC471675
0.9128 High Similarity NPC23668
0.9128 High Similarity NPC472580
0.9128 High Similarity NPC116604
0.9122 High Similarity NPC65775
0.9122 High Similarity NPC10027
0.9116 High Similarity NPC23728
0.9116 High Similarity NPC296998
0.9116 High Similarity NPC14001
0.9116 High Similarity NPC166757
0.9116 High Similarity NPC110303
0.9116 High Similarity NPC17816
0.9116 High Similarity NPC473077
0.911 High Similarity NPC155144
0.911 High Similarity NPC209040
0.911 High Similarity NPC469953
0.911 High Similarity NPC326500
0.911 High Similarity NPC216538
0.911 High Similarity NPC273538
0.9103 High Similarity NPC200694
0.9103 High Similarity NPC473042
0.9097 High Similarity NPC219917
0.9097 High Similarity NPC213659
0.9097 High Similarity NPC326109
0.9097 High Similarity NPC204088
0.9097 High Similarity NPC144118
0.9097 High Similarity NPC80962
0.9097 High Similarity NPC259166
0.9097 High Similarity NPC329215
0.9097 High Similarity NPC259007
0.9097 High Similarity NPC172250
0.9097 High Similarity NPC215311
0.9097 High Similarity NPC204985
0.9097 High Similarity NPC48624
0.9091 High Similarity NPC470668
0.9091 High Similarity NPC21350
0.9091 High Similarity NPC470669
0.9091 High Similarity NPC131130
0.9085 High Similarity NPC260296
0.9085 High Similarity NPC115432
0.9085 High Similarity NPC13408
0.9079 High Similarity NPC246647
0.9079 High Similarity NPC96342
0.9079 High Similarity NPC212967
0.9079 High Similarity NPC164110
0.9067 High Similarity NPC263676
0.9067 High Similarity NPC207624
0.9067 High Similarity NPC142308
0.9067 High Similarity NPC473996
0.9067 High Similarity NPC477957
0.906 High Similarity NPC476185
0.906 High Similarity NPC188403
0.906 High Similarity NPC321896
0.906 High Similarity NPC472421
0.906 High Similarity NPC61258
0.9054 High Similarity NPC160821
0.9054 High Similarity NPC132592
0.9054 High Similarity NPC244407
0.9054 High Similarity NPC296869
0.9048 High Similarity NPC178343
0.9048 High Similarity NPC20488
0.9048 High Similarity NPC306488
0.9048 High Similarity NPC5820
0.9048 High Similarity NPC83357
0.9048 High Similarity NPC267375
0.9048 High Similarity NPC111786
0.9048 High Similarity NPC88964
0.9048 High Similarity NPC301276
0.9048 High Similarity NPC195621
0.9048 High Similarity NPC214774
0.9048 High Similarity NPC54577
0.9048 High Similarity NPC176229
0.9048 High Similarity NPC154217
0.9048 High Similarity NPC475052
0.9048 High Similarity NPC67805
0.9048 High Similarity NPC470647
0.9048 High Similarity NPC312973
0.9048 High Similarity NPC246948
0.9048 High Similarity NPC142405

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC272194 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9241 High Similarity NPD7410 Clinical (unspecified phase)
0.911 High Similarity NPD4378 Clinical (unspecified phase)
0.8897 High Similarity NPD1243 Approved
0.8831 High Similarity NPD3749 Approved
0.8819 High Similarity NPD2796 Approved
0.8759 High Similarity NPD2344 Approved
0.875 High Similarity NPD1510 Phase 2
0.8732 High Similarity NPD1240 Approved
0.8699 High Similarity NPD1549 Phase 2
0.863 High Similarity NPD1550 Clinical (unspecified phase)
0.863 High Similarity NPD1552 Clinical (unspecified phase)
0.8627 High Similarity NPD7411 Suspended
0.8611 High Similarity NPD1607 Approved
0.8591 High Similarity NPD643 Clinical (unspecified phase)
0.8581 High Similarity NPD8443 Clinical (unspecified phase)
0.8562 High Similarity NPD4380 Phase 2
0.8523 High Similarity NPD2309 Approved
0.8516 High Similarity NPD2393 Clinical (unspecified phase)
0.8487 Intermediate Similarity NPD920 Approved
0.8477 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8471 Intermediate Similarity NPD7075 Discontinued
0.8411 Intermediate Similarity NPD1511 Approved
0.8408 Intermediate Similarity NPD7768 Phase 2
0.8397 Intermediate Similarity NPD7819 Suspended
0.8397 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8389 Intermediate Similarity NPD2800 Approved
0.8385 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD6801 Discontinued
0.8333 Intermediate Similarity NPD3750 Approved
0.8303 Intermediate Similarity NPD6559 Discontinued
0.8301 Intermediate Similarity NPD1512 Approved
0.8291 Intermediate Similarity NPD3882 Suspended
0.828 Intermediate Similarity NPD2801 Approved
0.8267 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8239 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD1934 Approved
0.8199 Intermediate Similarity NPD6959 Discontinued
0.817 Intermediate Similarity NPD6799 Approved
0.8075 Intermediate Similarity NPD919 Approved
0.8061 Intermediate Similarity NPD3818 Discontinued
0.8036 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD5494 Approved
0.8012 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD2799 Discontinued
0.8 Intermediate Similarity NPD3748 Approved
0.7988 Intermediate Similarity NPD3926 Phase 2
0.7975 Intermediate Similarity NPD1247 Approved
0.7975 Intermediate Similarity NPD6599 Discontinued
0.7961 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7959 Intermediate Similarity NPD2313 Discontinued
0.7947 Intermediate Similarity NPD2935 Discontinued
0.7947 Intermediate Similarity NPD1551 Phase 2
0.7939 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD6166 Phase 2
0.7939 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD6232 Discontinued
0.7892 Intermediate Similarity NPD7473 Discontinued
0.7888 Intermediate Similarity NPD2296 Approved
0.7888 Intermediate Similarity NPD3817 Phase 2
0.7885 Intermediate Similarity NPD2532 Approved
0.7885 Intermediate Similarity NPD2534 Approved
0.7885 Intermediate Similarity NPD2533 Approved
0.7867 Intermediate Similarity NPD6651 Approved
0.7838 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD6099 Approved
0.7829 Intermediate Similarity NPD6100 Approved
0.7811 Intermediate Similarity NPD5953 Discontinued
0.7808 Intermediate Similarity NPD2798 Approved
0.7785 Intermediate Similarity NPD5403 Approved
0.7778 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7763 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7759 Intermediate Similarity NPD4287 Approved
0.7742 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.774 Intermediate Similarity NPD1203 Approved
0.773 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7718 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7707 Intermediate Similarity NPD7390 Discontinued
0.7692 Intermediate Similarity NPD5844 Phase 1
0.7692 Intermediate Similarity NPD7054 Approved
0.7692 Intermediate Similarity NPD7286 Phase 2
0.7688 Intermediate Similarity NPD3226 Approved
0.7658 Intermediate Similarity NPD5401 Approved
0.7651 Intermediate Similarity NPD4625 Phase 3
0.7647 Intermediate Similarity NPD4308 Phase 3
0.7647 Intermediate Similarity NPD7472 Approved
0.7647 Intermediate Similarity NPD1729 Discontinued
0.7647 Intermediate Similarity NPD7033 Discontinued
0.7647 Intermediate Similarity NPD7074 Phase 3
0.7628 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD2797 Approved
0.7616 Intermediate Similarity NPD943 Approved
0.7602 Intermediate Similarity NPD6797 Phase 2
0.76 Intermediate Similarity NPD3764 Approved
0.76 Intermediate Similarity NPD3268 Approved
0.7586 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD422 Phase 1
0.7584 Intermediate Similarity NPD4908 Phase 1
0.7562 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD5402 Approved
0.7558 Intermediate Similarity NPD7251 Discontinued
0.7552 Intermediate Similarity NPD1548 Phase 1
0.7548 Intermediate Similarity NPD2346 Discontinued
0.7548 Intermediate Similarity NPD1471 Phase 3
0.7546 Intermediate Similarity NPD6280 Approved
0.7546 Intermediate Similarity NPD6279 Approved
0.7542 Intermediate Similarity NPD4361 Phase 2
0.7542 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7534 Intermediate Similarity NPD9717 Approved
0.7529 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD4628 Phase 3
0.7514 Intermediate Similarity NPD7808 Phase 3
0.7467 Intermediate Similarity NPD6832 Phase 2
0.7466 Intermediate Similarity NPD1610 Phase 2
0.7452 Intermediate Similarity NPD2654 Approved
0.7414 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD7003 Approved
0.7403 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD7229 Phase 3
0.7394 Intermediate Similarity NPD1465 Phase 2
0.7389 Intermediate Similarity NPD4363 Phase 3
0.7389 Intermediate Similarity NPD4360 Phase 2
0.7386 Intermediate Similarity NPD4307 Phase 2
0.7383 Intermediate Similarity NPD1164 Approved
0.7372 Intermediate Similarity NPD5405 Approved
0.7372 Intermediate Similarity NPD5408 Approved
0.7372 Intermediate Similarity NPD5406 Approved
0.7372 Intermediate Similarity NPD5404 Approved
0.7349 Intermediate Similarity NPD4288 Approved
0.7338 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD5124 Phase 1
0.7329 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD3225 Approved
0.7299 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD3972 Approved
0.7297 Intermediate Similarity NPD1608 Approved
0.7294 Intermediate Similarity NPD5710 Approved
0.7294 Intermediate Similarity NPD6808 Phase 2
0.7294 Intermediate Similarity NPD5711 Approved
0.7289 Intermediate Similarity NPD5761 Phase 2
0.7289 Intermediate Similarity NPD5760 Phase 2
0.7267 Intermediate Similarity NPD3267 Approved
0.7267 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD3266 Approved
0.7256 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD4749 Approved
0.7247 Intermediate Similarity NPD8434 Phase 2
0.723 Intermediate Similarity NPD1201 Approved
0.7212 Intermediate Similarity NPD6585 Discontinued
0.7209 Intermediate Similarity NPD4575 Clinical (unspecified phase)
0.7192 Intermediate Similarity NPD9545 Approved
0.7172 Intermediate Similarity NPD9493 Approved
0.7169 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD1470 Approved
0.7152 Intermediate Similarity NPD7458 Discontinued
0.7143 Intermediate Similarity NPD411 Approved
0.7143 Intermediate Similarity NPD7584 Approved
0.7143 Intermediate Similarity NPD1296 Phase 2
0.7135 Intermediate Similarity NPD7199 Phase 2
0.7126 Intermediate Similarity NPD5940 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD1933 Approved
0.7115 Intermediate Similarity NPD447 Suspended
0.711 Intermediate Similarity NPD2403 Approved
0.7097 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD17 Approved
0.7088 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD1876 Approved
0.7083 Intermediate Similarity NPD1241 Discontinued
0.7073 Intermediate Similarity NPD5049 Phase 3
0.7069 Intermediate Similarity NPD3446 Phase 1
0.7066 Intermediate Similarity NPD5889 Approved
0.7066 Intermediate Similarity NPD5890 Approved
0.7062 Intermediate Similarity NPD3658 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD6971 Discontinued
0.7059 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7052 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD2354 Approved
0.7032 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD6798 Discontinued
0.7029 Intermediate Similarity NPD7177 Discontinued
0.7029 Intermediate Similarity NPD3751 Discontinued
0.7027 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD7577 Discontinued
0.7006 Intermediate Similarity NPD230 Phase 1
0.7 Intermediate Similarity NPD4947 Clinical (unspecified phase)
0.6995 Remote Similarity NPD3269 Clinical (unspecified phase)
0.6983 Remote Similarity NPD8312 Approved
0.6983 Remote Similarity NPD8313 Approved
0.6981 Remote Similarity NPD651 Clinical (unspecified phase)
0.6978 Remote Similarity NPD8397 Clinical (unspecified phase)
0.697 Remote Similarity NPD6273 Approved
0.6966 Remote Similarity NPD6104 Discontinued
0.6957 Remote Similarity NPD2424 Discontinued
0.6948 Remote Similarity NPD2861 Phase 2
0.6943 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6943 Remote Similarity NPD1613 Approved
0.6941 Remote Similarity NPD5616 Clinical (unspecified phase)
0.6937 Remote Similarity NPD4477 Approved
0.6937 Remote Similarity NPD4476 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data